from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3367/PE_PGRS51

LFCtreatmentdescriptionclass of inhibitor

1.668

Amikacinug/mL Amikacintranslation

0.469

Cap5-10ug/mL Capreomycintranslation

2.009

Rox10-50 ug/mL Roxithromycintranslation

-0.766

SM2-5 ug/mL Streptomycintranslation

1.373

Tet5-10 ug/mL Tetracyclinetranslation

0.557

Rif0.2-5ug/mL Rifampicintranscription

-0.310

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.362

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.606

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.954

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.128

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.755

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.560

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.110

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.305

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.843

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.502

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.415

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.277

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.051

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.236

KCN5-20 ug/mL Potassium cyaniderespiration

-0.281

NaN30.2-2 mM Sodium aziderespiration

0.631

Nigericin50 uM Nigericinrespiration

0.304

TRC10-150 ug/mL Triclosanrespiration

0.335

TRZ10-25 ug/mL Thioridazinerespiration

2.430

Valinomycin0.5-10 uM Valinomycinrespiration

-0.586

ZnSO42 mM ZnSO4respiration

-0.618

menadione6-10 ug/mL Menadionerespiration

-0.046

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.334

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.142

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.295

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.047

NRP_1Non-replicating persistence stage 1dosRassociated

-0.792

Amp0.2mg/mL AmpicillincellWall

0.068

Cephalexin20-100 ug/mL CephalexincellWall

-0.948

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.109

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.629

EMB10-20 ug/mL EthambutolcellWall

-0.794

Eta12-40 ug/mL EthionamidecellWall

-0.385

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.429

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.034

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.007

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.012

BZA0.12 mg/mL BenzamidearomaticAmides

0.236

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.611

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.535

H2O24 mM hydrogen peroxideDNAdamaging

-0.251

Levo10 ug/mL LevofloxacinDNAdamaging

-0.387

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.155

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.283

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.257

UVUV-irradiationDNAdamaging

0.915

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.497

Antimycin12.5-50 ug/mL Antimycin A?

-0.553

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.099

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.075

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.781

PA8240.2-2 ug/mL PA-824?

0.532

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.056

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.380

Verapamil50 uM Verapamil?

-0.124

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.220

methoxatin10-20 ug/mL Methoxatin?